Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK

Trends in Pharmacological Sciences

Volumn 25, Issue 5, 2004, Pages 235-237

  Maser, Edmund ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; CARBONYL REDUCTASE; CARCINOGEN; GLYCYRRHETINIC ACID; KETONE DERIVATIVE; NICOTINE DERIVATIVE; NITROSAMINE; OXIDOREDUCTASE;

DETOXIFICATION; ENZYME ACTIVITY; GLYCYRRHIZA; HUMAN; METABOLISM; PRIORITY JOURNAL; REDUCTION; SHORT SURVEY; TOBACCO;

ALCOHOL OXIDOREDUCTASES; ANTI-INFLAMMATORY AGENTS; CARCINOGENS; GLYCYRRHETINIC ACID; HUMANS; LUNG NEOPLASMS; METABOLIC DETOXICATION, DRUG; NITROSAMINES;

EID: 2142825658     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.03.001     Document Type: Short Survey

References (21)

1. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91:1999;1194-1210
2. International Agency for Research on Cancer. Tobacco smoking. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 38:1986;127-163
3. Carmella S.G., et al. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res. 53:1993;721-724
4. Hecht S.S., et al. Quantitation of metabolites of 4-(methylnitrosamino)- 1-(3-pyridyl)-1- butanone after cessation of smokeless tobacco use. Cancer Res. 62:2002;129-134
5. Carmella S.G., et al. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in Human Urine. Chem. Res. Toxicol. 15:2002;545-550
6. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11:1998;559-603
7. Maser E. 11β-Hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone in mouse lung microsomes. Cancer Res. 58:1998;2996-3003
8. London S.J., et al. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and caucasians in Los Angeles county. Carcinogenesis. 18:1997;1203-1214
9. Maser E., et al. The identification of 11β-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur. J. Biochem. 238:1996;484-489
10. Atalla A., et al. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol. Xenobiotica. 30:2000;755-769
11. Penning T.M. Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action. Hum. Reprod. Update. 9:2003;193-205
12. Soldan M., et al. Interindividual variability in the expression and NNK carbonyl reductase activity of 11β-hydroxysteroid dehydrogenase 1 in human lung. Cancer Lett. 145:1999;49-56
13. Maser E. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? Trends Pharmacol. Sci. 18:1997;270-275
14. Higaki Y., et al. Selective and potent inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone. Chem. Biol. Interact. 143-144:2003;503-513
15. Ahrendt S.A., et al. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res. 60:2000;3155-3159
16. Valentino R., et al. Alcohol inhibits 11β-hydroxysteroid dehydrogenase activity in rat kidney and liver. Horm. Res. 43:1995;176-180
17. Monder C., et al. Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology. 125:1989;1046-1053
18. Reidenberg M.M. Environmental inhibition of 11β-hydroxysteroid dehydrogenase. Toxicology. 144:2000;107-111
19. Maser E., et al. Purification, characterization and NNK carbonyl reductase activities of 11β-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen. Chem. Biol. Interact. 143-144:2003;435-448
20. Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 1: cigarette design, testing approach, and review of results. Food Chem. Toxicol. 40:2002;77-91
21. Paolini M., et al. Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolizing enzymes. Cancer Lett. 145:1999;35-42